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Abstract
Background: Malaria is receding in many endemic countries with intervention scale -up against the disease.
However, this resilient scourge may persist in low-grade submicroscopic infections among semi-immune members
of the population, and be poised for possible resurgence, creating challenges for detection and assessment of
intervention impact. Parasite genotyping methods, such as the molecular barcode, can identify specific malaria
parasite types being transmitted and allow tracking and evaluation of parasite population structure changes as
interventions are applied. This current study demonstrates application of pre-amplification methods for successful
detection and genotyping of residual Plasmodium falciparum infections during a dramatic malarial decline.
Methods: The study was a prospective cross-sectional design and based on a 2,000 sq km vicinity of Macha Mission
Hospital in southern Zambia. Willing and predominantly asymptomatic residents of all ages were screened for
malaria by microscopy during the 2005 and 2008 transmission seasons, with simultaneous collection of dried blood
spots (DBS) on filter paper, and extraction of Plasmodium falciparum DNA was performed. Plasmodium falciparum
infections were genotyped using a 24 SNP-based molecular barcode assay using real-time PCR. Submicroscopic
parasitaemia samples were subjected to pre-amplification using TaqMan PreAmp Master Mix following the
manufacturer’s instructions before SNP barcode analysis.
Results: There was a dramatic decline of malaria between 2005 and 2008, and the geometric mean parasite
density (95% CI) fell from 704/μL (390–1,271) in 2005 to 39/μL (23–68) in 2008, culminating in a large proportion of
submicroscopic infections of which 90% failed to yield ample DNA for standard molecular characterization among
2008 samples. Pre-amplification enabled successful detection and genotyping of 74% of these low-grade reservoir
infections, overall, compared to 54% that were detectable before pre-amplification (p <0.0005, n = 84). Furthermore,
nine samples negative for parasites by microscopy and standard quantitative PCR amplification were positive after
pre-amplification.
Conclusions: Pre-amplification allows analysis of an otherwise undetectable parasite population and may be
instrumental for parasites identification, tracking and assessing the impact of interventions on parasite populations
during malaria control and elimination programmes when parasitaemia is expected to decline to submicroscopic
levels.
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Through support from the WHO Global Fund Rollback
Malaria (RBM) programme, the President’s Malaria Initia-
tive (PMI), Malaria Control and Evaluation Partnership
(MACEPA) and other public-private partnerships, endemic
countries are scaling up effective interventions against mal-
aria [1-4]. Declines in the malaria burden have since been
reported throughout sub-Saharan Africa [4]. Many coun-
tries, especially those situated towards the natural fringes
of malaria transmission, such as the southern African re-
gion, are aiming for possible elimination of the disease.
However, the malaria decline has not been universal,
both between and within countries [5], posing risks of
resurgence from this formidably resilient disease. Track-
ing changes in parasite population structure as it invari-
ably adapts to interventions is not only instrumental in
validating the impact of interventions on silent and non-
silent reservoirs, but also in devising strategies for better
targeting the scourge until its eventual elimination. As
the parasite is brought under control, one of its adaptive
strategies is to persist as silent low-grade carriage.
Harboured in semi-immune members of the community,
the predominantly submicroscopic infections evade not
only detection but also treatment, while presumably cap-
italizing on the opportunity for genomic adaptation to
overcome interventions. This asymptomatic reservoir is
believed to contribute to new infections and will need
to be identified and addressed for malaria elimination
to occur. The present study applies a pre-amplification
technique and demonstrates its utility for enhanced mo-
lecular detection and tracking of recalcitrant Plasmodium
falciparum populations during scaled up interventions.
Methods
Study area and population
The study was based in a 2,000 sq km vicinity of the
Malaria Institute at Macha (MIAM). This area is intrin-
sically hyperendemic for malaria and is transitioning to
hypoendemicity under scaled up interventions against
the disease. The resident population comprises essen-
tially stable subsistence farming communities of the
Batonga tribe. Ethical approval was obtained for the use
of these samples for parasite genotypic analysis.
Study design
The study consisted of prospective cross-sectional field
surveys for malaria from 2005 and 2008. Surveys were con-
ducted in villages that were selected by simple random
procedure each year, with individuals of all ages assembling
at pre-arranged meeting points for malaria screening.
Data and sample collection
Malaria screening was conducted by microscopy (2005
and 2008) or rapid diagnostic test (RDT, ICT Diagnostics
South Africa, 2008 only, Figure 1). Microscopy included
thick and thin blood film analysis performed later at the
MIAM laboratory each screening day or the following
morning. All individuals found positive by RDT (in 2008)
or later by microscopy (in 2005 and 2008) were treated
using artemether-lumefantrine following national guide-
lines, irrespective of whether or not they had symptoms.
Dry blood spots (DBS) were collected on filter paper from
all patients for subsequent parasite genotyping analysis.
Sample pre-amplification
Plasmodium falciparum DNA was extracted from DBS
samples using the Promega DNA IQ Casework Pro Kit
for Maxwell 16 (Promega Corp., Madison, WI, USA) fol-
lowing the manufacturer’s instructions. Real-time DNA
quantification was performed on resultant sample extracts
to determine DNA content, as described by Daniels et al.
[6]. Briefly, 3 μL of each extracted sample was used to de-
termine the parasite template concentration in triplicate
using a TaqMan assay designed to amplify PF3D7_0718800
(formerly PF07_0076), a single-copy conserved protein
with unknown function. Lab-adapted P. falciparum strains
were used as standards in the quantitative real-time reac-
tion with a total reaction volume of 5 μL.
The P. falciparum infection samples from 2005 and
2008 were subjected to polymorphic analysis using a 24
SNP-based parasite molecular barcode assay on an ABI
7900 real-time PCR system, also as described by Daniels
et al. [6]. The molecular barcode is a set of 24 SNP
genotyping assays selected from across the P. falciparum
genome to be selectively neutral; concatenating the geno-
types from these independent assays generates what is
known as the molecular barcode. Samples from low-grade
infections, which gave DNA concentrations below the de-
tectable threshold for the barcode assay (0.005 ng/μL),
were subjected to pre-amplification (PreAmp Master Mix,
Life Technologies, Inc, Grand Island, NY, USA) to en-
hance the template concentration specifically in the re-
gions interrogated by the molecular barcode, following
the manufacturer’s instructions. Pre-amplification reac-
tions comprised 5 μL template DNA extract, 1X Taq-
Man assay mixture containing 0.2x TaqMan barcoding
and quantification primers, and 1X Preamp master mix
in 20 μL total volumes. Following pre-amplification,
samples were re-quantified as described above.
Several other master mixes were also evaluated to de-
termine which offered the best performance, testing a
master mix from another vendor (Roche cDNA Pre-Amp
Master, Roche Applied Science, Mannheim, Germany)
and a standard genotyping master mix (Life Technologies
TaqMan Universal PCR Master Mix, No AmpErase UNG)
under the same pre-amplification thermal cycler condi-
tions described above.
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Differences in DNA yields from field DBS extracts for
protocols with and without pre-amplification were tested
using McNemar’s Chi-square and the paired t-test for
quantitative data. Temporal changes in parasitaemia and
demographic profiles were examined using Student’s
t-test and Mantel-Haenzel’s Chi-square, respectively.
Results
Background characteristics
There were no significant differences in human demo-
graphic characteristics for field samples from 2005
and 2008. However, P. falciparum infections exhibited
substantially lower parasite densities in 2008 com-
pared to 2005 (Table 1). All samples were from asymp-
tomatic carriers in the resident population.
Plasmodium falciparum DNA yields from field samples
with and without pre-amplification
With declining parasite densities between 2005 and 2008,
an increasing proportion of samples could not be directly
genotyped after extraction since yields of P. falciparum
DNA concentrations fell below the 0.005 ng/uL threshold
[6] for reliable barcode assay analysis (Table 2). This con-
straint was severe among samples from 2008 as compared
to 2005, with both lower average DNA concentration, and
Screening by microscopy (2005 and 2008) 
Negative
(1306)
Random sampling
(31)
Positive
(53)
Real-time PCR Quantitation
(84)
Negative [ 0.005 ng/uL]
(73)
Positive [ 0.005 ng/uL]
(11)
Molecular barcode assay
Negative
(23)
Positive
(50)
Real-time PCR 
Quantitation
Figure 1 Flowchart of samples collected, processed and analyzed for this study using the molecular barcode assay.
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2008 samples (Table 2), consistent with declining parasite
densities (Table 1).
However, application of pre-amplification led to sub-
stantially more samples with sufficient DNA concentra-
tions to yield a DNA signal (Table 3). Of the 84 field
samples tested, 53 (63%) were microscopy-positive. Even
among microscopy-positive samples, 30 (35.7% overall)
failed standard qPCR. With pre-amplification, the num-
ber of untypable low parasitaemia samples was reduced
to 23 (27.3% overall). Furthermore, of 31 samples nega-
tive by RDT or microscopy as well as by qPCR, nine
yielded a molecular barcode after pre-amplification.
Quality control measures (negative no-template controls,
repeated trials with the original sample material and
unique barcode results for the amplified samples) ruled
out cross-contamination to explain this observation. Al-
though all reasonable precautions were taken in the field
and in the laboratory, we cannot completely rule out the
possibility that any of these samples were mis-labeled;
however, our detection threshold experiments indicate
that our observation of molecular barcodes from sam-
ples considered to be negative by standard methodolo-
gies is likely to be valid.
Detection thresholds
The limits of detection for this pre-amplification ap-
proach were determined using serial dilution of standard
DNA samples. Pre-amplification of samples resulted in
reliable barcode data among samples containing as low
as 0.00015 ng/μL DNA. Without pre-amplification, the
lowest detectable sample DNA concentration for reliable
barcode detection required 100X greater DNA concen-
tration (0.015 ng/μL) (see Additional files 1 and 2). This
threshold was higher than the 0.005 ng/μL determined
in early studies using an older rotary glass capillary-
based real-time PCR machine. Three of nine submicro-
scopic samples successfully typed after pre-amplification
were also negative by standard nested PCR.
The method of pre-amplification was further evaluated by
testing the performance of an additional pre-amplification
mix from another vendor as well as the standard molecular
barcode genotyping mix under the same pre-amplification
conditions. The Roche cDNA Pre-Amp Master also ampli-
fied templates at concentrations lower than the standard
limit of detection for the molecular barcode assay, but had a
higher threshold to produce a complete molecular barcode
compared to the Applied Biosystems product (0.001 ng vs.
0.00015 ng). The standard genotyping master mix did not
improve the product yield compared to both of these pre-
amplification products (see Additional file 3).
Discussion
As malaria recedes under scaled-up interventions ap-
plied in endemic countries, the formidable scourge of
malaria is increasingly assuming subpatent infections in
semi-immune, asymptomatic segments of the population
[7]. These submicroscopic infections pose a new chal-
lenge, not only as a reservoir for possible resurgence,
but also for detection, documentation and tracking of
intervention impact on the parasite.
The current study shows that the average parasite
density of P. falciparum parasitaemia in the Macha area
of southern Zambia decreased substantially between
2005 and 2008. There was a clear preponderance of sub-
microscopic, and hence sub-RDT, infections in 2008,
which were much less amenable to detection and geno-
typing than samples from 2005.
Here the application of a TaqMan pre-amplification
assay demonstrated that this approach significantly in-
creased the proportion of low-parasitaemia field samples
that could undergo molecular genotyping, leading to
Table 2 DNA yield from standard extraction among 2005
and 2008 DBS samples (n= 84)
2005 2008 p-value
Samples with insufficient DNA
signal (n) 79.2% (42/53) 100% (31/31) <0.0005
Mean DNA concentration
(ng/μL) in extracts [95% CI] 0.0003068 0.000042 <0.0005
Table 3 DNA yields from dried blood spot field samples
before and after pre-amplification
Before
pre-amplification
After
pre-amplification p-value
Samples with
insufficient
DNA signal (%)
73 (86.9%) 23 (27.3%) <0.0005
Mean DNA
concentration
(ng/μL) in extracts
0.0001712 0.1301491
<0.0005
[95% CI] [0.0001089-
0.0002335]
[0.0864078-
0.1738905]
Table 1 Parasite densities from Plasmodium falciparum
samples and corresponding host characteristics
2005 2008 p-value
GMPD (/μL) 704 39
< 0.0005 [95% CI] [390–1,271] [23–68]
Parasite density (/μL) range 35–48,569 8–171
Mean axillary temperature (°C) 36.4 36.6
0.239
[95% CI] 36.2–36.6 [36.3–36.8]
Mean age (years) 91 3
0.08
[95% CI] [8.2–10.7] [5.0–21.9]
Males (%) 52 27 0.138
(GMPD, geometric mean parasite density [for positives only, n = 42 and 11,
respectively for 2005 and 2008]; for all samples n = 53 and 31, respectively in
2005 and 2008).
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molecular barcode technique. More work will be re-
quired to substantiate the observations reported here,
and to understand the impact of asymptomatic carriage,
for example, on persistent malaria infection and trans-
mission. Although other methodologies, such as nested
PCR, can amplify DNA signals from low-yield samples,
these approaches only allow amplification of one gene at
a time. Pre-amplification, on the other hand, works with
up to 100 short (less than 150 bp) amplicon assays in a
single reaction, thus allowing genotyping of multiple
loci. The amplification conditions, primarily the low
primer concentration, limited number of amplification
cycles, and increased extension time, together reduce
chimera formation and maintain sample integrity. This
strategy is not specific to TaqMan-based assays, and pre-
amplification has been successfully incorporated for used
in gene-specific assays as well as high-resolution melting
assays for drug resistance genotyping [8].
By overcoming the detection challenge posed by these
low-grade silent infections, pre-amplification may aid in
monitoring intervention efficacy, tracking of the last bas-
tions of residual parasites and thwarting potential resur-
gences during malaria control and elimination programs.
As malaria-endemic regions reduce malaria transmission
and work toward elimination, it will become critical to
have tools and strategies to identify and track asymp-
tomatic carriers, with highly reduced parasitaemia, that
contribute to incident infections.
Conclusions
The TaqMan pre-amplification assay provides a means
for sensitive detection and tracking of residual P.
falciparum infections during malaria control and elim-
ination programmes.
Additional files
Additional file 1: Real-time PCR cycle threshold (Ct) values for
barcode SNPs, at decreasing concentrations of input Plasmodium
falciparum 3D7 DNA, either with or without pre-amplification.
Eight samples (numbered 1 through 8) of 3D7 DNA at variable input
concentrations ranging from 15 to 0.0000015 nanograms (ng) are shown
with or without pre-amplification (PA). Resulting Ct values for each
molecular barcode assay (numbered 1 through 24) are shown with UD
(undetermined) indicating that a Ct value could not be determined due
to low amplicon signal.
Additional file 2: Genotyping results for barcode SNPs, at
decreasing concentrations of input Plasmodium falciparum 3D7
DNA, either with or without pre-amplification. Eight samples
(numbered 1 through 8) of 3D7 DNA at variable input concentrations
ranging from 15 to 0.0000015 nanograms (ng) are shown with or without
pre-amplification (preamp). Resulting calls for each molecular barcode
assay (identified by SNP assay chromosome and coordinate) are shown
with a “dash” (−) indicating that the genotyping call could not be
determined for that assay. “Blank” indicates a no template control.
Additional file 3: Genotyping results from alternative pre-
amplification kits. Amplification of the 24 molecular barcode assays
(identified by chromosome and coordinate number) from control
samples (amplified using TaqMan Universal PCR Master Mix, no AmpErase
UNG) or Roche samples (amplified using the Roche Realtime Ready pre-
amp Master Mix) at various concentrations of input 3D7 P. falciparum
DNA ranging from 1 to 0.0001 nanograms (ng). A “dash” (−) indicates that
the genotyping call could not be determined for that assay.
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